Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Stryve Foods, Inc. Announces Preliminary FY 2024 Financials and Filing of Form 12b-25 to Extend Time to File FY 2024 Annual Report

In This Article:

Stryve Foods, Inc.
Stryve Foods, Inc.

Full Year ‘24 Net Sales of $21.0 Million Up 18.5% Year-over-Year
Adjusted EBITDA Loss Improved by 32.4% Versus Prior Year
Significant Balance Sheet Transformation Underway in 2025

PLANO, Texas, April 01, 2025 (GLOBE NEWSWIRE) -- Stryve Foods, Inc. (OTC: SNAX) (“Stryve” or the “Company”), a leader in high-protein, better-for-you snacking, today unaudited preliminary Q4 2024 financial information and disclosed it had filed form 12b-25 for their Form 10K for the fiscal year ended December 31, 2024.

FY 2024 Unaudited Preliminary financial information

The unaudited preliminary financial information as of and for the year ended December 31, 2024, is as follows. The Company expects net sales of $21.0 million an increase of 18.5% versus the prior year, incur an operating loss of approximately $10.6 million an improvement of 31.2% versus the prior year, and used cash in operating activities of approximately $7.9 million. These figures compare to net sales of $17.7 million, an operating loss of $15.4 million, and cash used in operating activities of $7.4 million during the year ended December 31, 2023. The Company also expects an adjusted EBITDA loss¹ of $8.0 million, which represents a 32.4% improvement compared to $11.8 million in the prior year. As of December 31, 2024, the Company had a working capital deficit of approximately $15.0 million as compared to $7.4 million as of December 31, 2023, and had approximately $16.4 million of indebtedness.

In the fourth quarter of 2024, the Company achieved net sales of $4.5 million which is up 57.5% versus the same period in 2023. Additionally, the Company’s operating loss and adjusted EBITDA for the fourth quarter of 2024 were $3.1 million and $2.4 million respectively which compare favorably to $4.2 million and $3.4 million from 2023 representing a 26.5% and 28.5% improvement in each.

Since year-end 2024, the Company has completed two significant transactions to transform its balance sheet. On January 30th, 2025, the Company reduced its current liabilities by $8.7 million through a preferred equity transaction. Additionally, on February 15th, 2025, the Company successfully exited a distribution facility operating lease which has eliminated over $10.2 million of future lease payments.

The Company’s working capital position has remained constrained limiting its ability to fully realize and execute on the demand for its products. Until the Company can generate positive cash flow from operations, the Company expects to finance its operations through equity offerings, debt financings, other financing or strategic transactions. There can be no assurance that the Company will be successful in raising additional capital or that such capital, if available, will be on terms that are acceptable.